Indeed, in a study conducted on 87 breast cancer patients treated with neoadjuvant chemotherapy, LEP and LEPR overexpression, were found in patients with higher levels of tumor-infiltrating lymphocytes (TILs). The gene discussed is LEP; the disease is neoplasm.